نتایج جستجو برای: fibroblast growth factor 2

تعداد نتایج: 3676118  

Journal: :Acta biomaterialia 2012
Lara C Ionescu Gregory C Lee Kevin L Huang Robert L Mauck

Few therapeutic options exist for meniscus repair after injury. Local delivery of growth factors may stimulate repair and create a favorable environment for engineered replacement materials. In this study we assessed the effect of basic fibroblast growth factor (bFGF) (a pro-mitotic agent) and transforming growth factor β3 (TGF-β3) (a pro-matrix formation agent) on meniscus repair and the integ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2001
K Neben T Moehler G Egerer A Kraemer J Hillengass A Benner A D Ho H Goldschmidt

The aim of this study was to define prognostic factors that might be predictive for response to thalidomide (Thal) in progressive multiple myeloma (n = 54). We examined the concentration of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), two potent heparin-binding mediators of angiogenesis in peripheral blood (PB; PB-VEGF and PB-bFGF) and bone marrow (BM; BM...

2008
Wanda J. Gordon-Evans Michael J. Yaeger Heather Greenlee Michael G. Conzemius

This study investigated the effect of fibroblast growth factor 2 in monolayer followed by transforming growth factor 1 in 3-dimensional culture on chondrocytic matrix production. Under the culture conditions presented, FGF2 is mitogenic but not chondrogenic. In addition, TGF 1 stimulation produced predominantly type I collagen.

Journal: :The Journal of clinical investigation 2007
Lars Johan Nissen Renhai Cao Eva-Maria Hedlund Zongwei Wang Xing Zhao Daniel Wetterskog Keiko Funa Ebba Bråkenhielm Yihai Cao

Tumors produce multiple growth factors, but little is known about the interplay between various angiogenic factors in promoting tumor angiogenesis, growth, and metastasis. Here we show that 2 angiogenic factors frequently upregulated in tumors, PDGF-BB and FGF2, synergistically promote tumor angiogenesis and pulmonary metastasis. Simultaneous overexpression of PDGF-BB and FGF2 in murine fibrosa...

Journal: :Cancer discovery 2017
Lipika Goyal Supriya K Saha Leah Y Liu Giulia Siravegna Ignaty Leshchiner Leanne G Ahronian Jochen K Lennerz Phuong Vu Vikram Deshpande Avinash Kambadakone Benedetta Mussolin Stephanie Reyes Laura Henderson Jiaoyuan Elisabeth Sun Emily E Van Seventer Joseph M Gurski Sabrina Baltschukat Barbara Schacher-Engstler Louise Barys Christelle Stamm Pascal Furet David P Ryan James R Stone A John Iafrate Gad Getz Diana Graus Porta Ralph Tiedt Alberto Bardelli Dejan Juric Ryan B Corcoran Nabeel Bardeesy Andrew X Zhu

Genetic alterations in the fibroblast growth factor receptor (FGFR) pathway are promising therapeutic targets in many cancers, including intrahepatic cholangiocarcinoma (ICC). The FGFR inhibitor BGJ398 displayed encouraging efficacy in patients with FGFR2 fusion-positive ICC in a phase II trial, but the durability of response was limited in some patients. Here, we report the molecular basis for...

Journal: :The Journal of Cell Biology 1989
D Moscatelli N Quarto

When NIH 3T3 cells were transfected with the cDNA for basic fibroblast growth factor (bFGF), most cells displayed a transformed phenotype. Acquisition of a transformed phenotype was correlated with the expression of high levels of bFGF (Quarto et al., 1989). Cells that had been transformed as a result of transfection with bFGF cDNA had a decreased capacity to bind 125I-bFGF to high affinity rec...

Journal: :Cancer research 2015
Junko Tanizaki Dalia Ercan Marzia Capelletti Michael Dodge Chunxiao Xu Magda Bahcall Erin M Tricker Mohit Butaney Antonio Calles Lynette M Sholl Peter S Hammerman Geoffrey R Oxnard Kwok-Kin Wong Pasi A Jänne

The discovery of oncogenic driver mutations and the subsequent developments in targeted therapies have led to improved outcomes for subsets of lung cancer patients. The identification of additional oncogenic and drug-sensitive alterations may similarly lead to new therapeutic approaches for lung cancer. We identify and characterize novel FGFR2 extracellular domain insertion mutations and demons...

Journal: :Endocrinology 1998
E E Mancilla F De Luca J A Uyeda F S Czerwiec J Baron

In vivo, fibroblast growth factor-2 (FGF-2) inhibits longitudinal bone growth. Similarly, activating FGF receptor 3 mutations impair growth in achondroplasia and thanatophoric dysplasia. To investigate the underlying mechanisms, we chose a fetal rat metatarsal organ culture system that would maintain growth plate histological architecture. Addition of FGF-2 to the serum-free medium inhibited lo...

2014
Harmanpreet Kaur Hasan Uludağ Tarek El-Bialy

OBJECTIVE Basic fibroblast growth factor (bFGF) is an important regulator of tissue growth. Previous studies have shown that low intensity pulsed ultrasound (LIPUS) stimulates bone growth. The objective of this study was to evaluate the possible synergetic effect of LIPUS and local injection of nonviral bFGF plasmid DNA (pDNA) on mandibular growth in rats. DESIGN Groups were control, blank pD...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید